Toxoplasma gondii inhibits covalent modification of histone H3 at the IL-10 promoter in infected macrophages

PLoS ONE

Volumn 4, Issue 10, 2009, Pages

  Leng, Jin ^a   Denkers, Eric Y ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; HISTONE H3; INTERLEUKIN 10; TOLL LIKE RECEPTOR 4; HISTONE; LIPOPOLYSACCHARIDE; SERINE;

ACETYLATION; ANIMAL CELL; ARTICLE; CHROMATIN ASSEMBLY AND DISASSEMBLY; CONTROLLED STUDY; COVALENT BOND; CYTOKINE PRODUCTION; DOWN REGULATION; HOST PATHOGEN INTERACTION; IMMUNOSTIMULATION; MACROPHAGE; MOUSE; NONHUMAN; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; TOXOPLASMA GONDII; TOXOPLASMOSIS; ANIMAL; BONE MARROW CELL; C57BL MOUSE; CHEMISTRY; FIBROBLAST; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PARASITOLOGY; PHOSPHORYLATION; PROMOTER REGION; TOXOPLASMA;

PROTOZOA; TOXOPLASMA; TOXOPLASMA GONDII;

ANIMALS; BONE MARROW CELLS; FIBROBLASTS; GENE EXPRESSION REGULATION; HISTONES; HUMANS; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MICE, INBRED C57BL; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; RECEPTORS, IGG; SERINE; TOLL-LIKE RECEPTOR 4; TOXOPLASMA;

EID: 70449568923     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0007589     Document Type: Article

References (28)

1. Montoya JG, Liesenfeld O (2004) Toxoplasmosis. Lancet 363: 1965-1976.
2. Peterson E, Liesenfeld O (2007) Clinical disease and diagnostics. In: Weiss LM, Kim K, eds. Toxoplasma gondii The model apicomplexan: Perspectives and methods. Amsterdam: Academic Press. pp 81-100.
3. Bierly AL, Shufesky WJ, Sukhumavasi W, Morelli A, Denkers EY (2008) Dendritic cells expressing plasmacytoid marker PDCA-1 are Trojan horses during Toxoplasma gondii infection. J Immunol 181: 8445-8491.
4. Butcher BA, Kim L, Johnson PF, Denkers EY (2001) Toxoplasma gondii tachyzoites inhibit proinflammatory cytokine induction in infected macrophages by preventing nuclear translocation of the transcription factor NF-kappa B. J Immunol 167: 2193-2201.
5. McKee AS, Dzierszinski F, Boes M, Roos DS, Pearce EJ (2004) Functional inactivation of immature dendritic cells by the intracellular protozoan Toxoplasma gondii. J Immunol 173: 2632-2640.
6. Leng J, Butcher BA, Denkers EY (2009) Dysregulation of macrophage signal transduction by Toxoplasma gondii: Past progress and recent advances. Parasite Immunol. In press.
7. Lang C, Algner M, Beinert N, Gross U, Luder CG (2006) Diverse mechanisms employed by Toxoplasma gondii to inhibit IFN-gamma-induced major histocompatibility complex class II gene expression. Microbes Infect 8: 1994-2005.
8. Luder CGK, Algner M, Lang C, Bleicher N, Gross U (2003) Reduced expression of the inducible nitric oxide synthase after infection with Toxoplasma gondii facilitates parasite replication in activated murine macrophages. Internat J Parasitol 33: 833-844.
9. Kim L, Butcher BA, Denkers EY (2004) Toxoplasma gondii interferes with lipopolysaccharide-induced mitogen-activated protein kinase activation by mechanisms distinct from endotoxin tolerance. J Immunol 172: 3003-3010.
10. Lee CW, Bennouna S, Denkers EY (2006) Screening for Toxoplasma gondii-regulated transcriptional responses in lipopolysaccharide-activated macrophages. Infect Immun 74: 1916-1923.
11. Leng J, Butcher BA, Egan CE, Abdallah DS, Denkers EY (2009) Toxoplasma gondii prevents chromatin remodeling initiated by TLR-triggered macrophage activation. J Immunol 182: 489-497.
12. Berger SL (2007) The complex language of chromatin regulation during transcription. Nature 447: 407-412.
13. Lucas M, Zhang X, Prasanna V, Mosser DM (2005) ERK activation following macrophage FcgammaR ligation leads to chromatin modifications at the IL-10 locus. J Immunol 175: 469-477.
14. Zhang X, Edwards JP, Mosser DM (2006) Dynamic and transient remodeling of the macrophage IL-10 promoter during transcription. J Immunol 177: 1282-1288.
15. Pestka S, Krause CD, Sarkar D, Walter MR, Shi Y, et al. (2004) Interleukin-10 and related cytokines and receptors. Annu Rev Immunol 22: 929-979.
16. 4+ T cells and accompanied by overproduction of IL-12, IFN-γ, and TNF-α. J Immunol 157: 798-805.
17. Suzuki Y, Sher A, Yap G, Park D, Ellis Neyer L, et al. (2000) IL-10 is required for prevention of necrosis in the small intestine and mortality in both genetically resistant BALB/c and susceptible C57BL/6 mice following peroral infection with Toxoplasma gondii. J Immunol 164: 5375-5382.
18. Wilson EH, Wille-Reece U, Dzierszinski F, Hunter CA (2005) A critical role for IL-10 in limiting inflammation during toxoplasmic encephalitis. J Neuroimmunol 165: 63-74.
19. Luder CGK, Walter W, Beuerle B, Maeurer MJ, Gross U (2001) Toxoplasma gondii down-regulates MHC class II gene expression and antigen presentation by murine macrophages via interference with nuclear translocation of STAT1α. Eur J Immunol 31: 1475-1484.
20. Kim SK, Fouts AE, Boothroyd JC (2007) Toxoplasma gondii dysregulates IFN-gamma-inducible gene expression in human fibroblasts: insights from a genomewide transcriptional profiling. J Immunol 178: 5154-5165.
21. Gilbert LA, Ravindran S, Turetzky JM, Boothroyd JC, Bradley PJ (2007) Toxoplasma gondii targets a protein phosphatase 2C to the nuclei of infected host cells. Eukaryot Cell 6: 73-83.
22. Saeij JP, Boyle JP, Coller S, Taylor S, Sibley LD, et al. (2006) Polymorphic secreted kinases are key virulence factors in toxoplasmosis. Science 314: 1780-1783.
23. Saeij JP, Coller S, Boyle JP, Jerome ME, White MW, et al. (2007) Toxoplasma co-opts host gene expression by injection of a polymorphic kinase homologue. Nature 445: 324-327.
24. Taylor S, Barragan A, Su C, Fux B, Fentress SJ, et al. (2006) A secreted serine-threonine kinase determines virulence in the eukaryotic pathogen Toxoplasma gondii. Science 314: 1776-1780.
25. Arbibe L, Kim DW, Batsche E, Pedron T, Mateescu B, et al. (2007) An injected bacterial effector targets chromatin access for transcription factor NF-kappaB to alter transcription of host genes involved in immune responses. Nat Immunol 8: 47-56.
26. Hamon MA, Batsche E, Regnault B, Tham TN, Seveau S, et al. (2007) Histone modifications induced by a family of bacterial toxins. Proc Natl Acad Sci U S A 104: 13467-13472.
27. Hamon MA, Cossart P (2008) Histone modifications and chromatin remodeling during bacterial infections. Cell Host Microbe 4: 100-109.
28. Wang Y, Curry HM, Zwilling BS, Lafuse WP (2005) Mycobacteria inhibition of IFN-gamma induced HLA-DR gene expression by up-regulating histone deacetylation at the promoter region in human THP-1 monocytic cells. J Immunol 174: 5687-5694.